Cosmos Health Inc (COSM)

$1.02 -0.01 (-0.97%)
Market Cap 31.94M
Revenue (ttm) 54.43M
Net Income (ttm) -16.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -29.73%
Debt to Equity Ratio 0.39
Volume 658,800
Avg Vol 834,676
Day's Range N/A - N/A
Shares Out 31.01M
Stochastic %K 15%
Beta 5.36
Analysts Strong Buy
Price Target $3.00

Company Profile

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvas...

Industry: Medical Distribution
Sector: Healthcare
Phone: 312 536 3102
Address:
141 West Jackson Boulevard, Suite 4236, Chicago, United States
YanstersParadise
YanstersParadise Oct. 25 at 12:51 PM
$ASST $COSM $TGL $LUXX.CSE 🔥🔥🔥🔥Crypto Treasury 🔥🔥🔥🔥 🚨🚨🚨💎💎💎💎💎💎💎💎🚨🚨🚨
1 · Reply
Luvmepup
Luvmepup Oct. 25 at 12:32 PM
$COSM Baggies more worried about people posting than this crooked CEO constantly drilling them in the ass 🙄
0 · Reply
Dastock87
Dastock87 Oct. 25 at 12:20 PM
$COSM what's up with this Pup guy? He posts every 5min...
1 · Reply
Luvmepup
Luvmepup Oct. 25 at 12:07 PM
$COSM Charts showing very bullish today and tomorrow with a probable dip come Monday.
0 · Reply
Xenocyde
Xenocyde Oct. 25 at 2:21 AM
$COSM a lot of tough talk for someone who made some very very bold dumper claims this week. What was that about wouldn’t hold a dollar.
0 · Reply
Luvmepup
Luvmepup Oct. 25 at 1:56 AM
$COSM We Shorts really put an ass whooping on you baggies/bulls this week ... so much so, you people had hardly anything to try and pump about!
0 · Reply
BigPlaySnipers
BigPlaySnipers Oct. 24 at 9:45 PM
$ASST = $RR $COSM $OPEN vibes …
0 · Reply
Luvmepup
Luvmepup Oct. 24 at 8:12 PM
$COSM I don't think you baggies/bulls realize whats going on right now. That 1.02 offering is not only killing you in stock price, but it's also adding millions more to the float! Once they are done, this stock is really going to take a huge shit ... you watch!
0 · Reply
Luvmepup
Luvmepup Oct. 24 at 6:44 PM
$COSM Wheres your crooked CEO after getting his compliancee?
0 · Reply
BlackLamaPijama
BlackLamaPijama Oct. 24 at 6:43 PM
$COSM $DJT Yup. Let's get those Epstein files out.
0 · Reply
Latest News on COSM
Cosmos Health Expands Its Ethereum Holdings With an Additional $200,000 Purchase Under Its $300 Million Digital Assets Facility; Total Investment Now Reaches $2 Million

Oct 21, 2025, 12:10 PM EDT - 4 days ago

Cosmos Health Expands Its Ethereum Holdings With an Additional $200,000 Purchase Under Its $300 Million Digital Assets Facility; Total Investment Now Reaches $2 Million

Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million

Oct 13, 2025, 2:05 PM EDT - 12 days ago

Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million

Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility

Oct 10, 2025, 8:00 AM EDT - 15 days ago

Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility

Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive Distribution Agreement With Diyar United and Secures Initial Purchase Order of Over 65,000 Units

Oct 3, 2025, 3:56 PM EDT - 22 days ago

Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive Distribution Agreement With Diyar United and Secures Initial Purchase Order of Over 65,000 Units

Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation

Sep 29, 2025, 8:00 AM EDT - 26 days ago

Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation

Cosmos Health Expands Order Book with Contract Manufacturing Agreement with Medical Pharmaquality S.A. for 3 Million MYCOFAGYL® Pessaries Annually

Sep 25, 2025, 8:00 AM EDT - 4 weeks ago

Cosmos Health Expands Order Book with Contract Manufacturing Agreement with Medical Pharmaquality S.A. for 3 Million MYCOFAGYL® Pessaries Annually

Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue

Sep 22, 2025, 8:00 AM EDT - 4 weeks ago

Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue

Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units

Sep 11, 2025, 8:00 AM EDT - 6 weeks ago

Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units

Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025

Aug 18, 2025, 12:45 PM EDT - 2 months ago

Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025

Cosmos Health Makes Initial $1M Ethereum Purchase Under Digital Asset Treasury Strategy

Aug 12, 2025, 9:50 AM EDT - 2 months ago

Cosmos Health Makes Initial $1M Ethereum Purchase Under Digital Asset Treasury Strategy

Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy

Aug 6, 2025, 9:20 AM EDT - 2 months ago

Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy

Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech

Jun 24, 2025, 10:55 AM EDT - 4 months ago

Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech

RETRANSMISSION – Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

May 15, 2025, 2:30 PM EDT - 5 months ago

RETRANSMISSION – Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

May 15, 2025, 9:30 AM EDT - 5 months ago

Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units

May 7, 2025, 2:30 PM EDT - 6 months ago

Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units

Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq

May 6, 2025, 1:40 PM EDT - 6 months ago

Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq

Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000

Apr 30, 2025, 12:50 PM EDT - 6 months ago

Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000

Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million

Apr 16, 2025, 12:45 PM EDT - 6 months ago

Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million

Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L

Apr 9, 2025, 1:40 PM EDT - 7 months ago

Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L

Cosmos Health Launches Sky Premium Life in Albania through Partnership with Pharma Cell; Secures Initial $300,000 Order

Apr 8, 2025, 10:45 AM EDT - 7 months ago

Cosmos Health Launches Sky Premium Life in Albania through Partnership with Pharma Cell; Secures Initial $300,000 Order

Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates

Feb 26, 2025, 11:30 AM EST - 8 months ago

Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates

Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1

Feb 18, 2025, 8:30 AM EST - 8 months ago

Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1

Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market

Feb 11, 2025, 10:15 AM EST - 9 months ago

Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market

Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market

Feb 10, 2025, 1:30 PM EST - 9 months ago

Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market

Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations

Feb 10, 2025, 9:45 AM EST - 9 months ago

Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations

Cosmos Health Secures 10-Year Long-Term Contract Manufacturing Order from Provident Pharmaceuticals for 4 Additional Products, Totaling 8 Million Packs, Significantly Expanding High-Margin Revenue Backlog and Cash Flow Visibility

Feb 7, 2025, 10:00 AM EST - 9 months ago

Cosmos Health Secures 10-Year Long-Term Contract Manufacturing Order from Provident Pharmaceuticals for 4 Additional Products, Totaling 8 Million Packs, Significantly Expanding High-Margin Revenue Backlog and Cash Flow Visibility

Cosmos Health Receives $578,460 Initial Purchase Order from Al Rabwa International for Sky Premium Life Food Supplements in Qatar

Feb 6, 2025, 3:50 PM EST - 9 months ago

Cosmos Health Receives $578,460 Initial Purchase Order from Al Rabwa International for Sky Premium Life Food Supplements in Qatar

Cosmos Health Files New AI-Driven Patent Application for Multiple Sclerosis Treatment, Targeting $25 Billion+ Global Market

Feb 5, 2025, 11:05 AM EST - 9 months ago

Cosmos Health Files New AI-Driven Patent Application for Multiple Sclerosis Treatment, Targeting $25 Billion+ Global Market

Cosmos Health Secures Bond Loan from European Bank on Very Competitive Terms, with Option to Upsize to Support Growth and Achieve Positive Operating Cash Flow

Jan 28, 2025, 11:00 AM EST - 9 months ago

Cosmos Health Secures Bond Loan from European Bank on Very Competitive Terms, with Option to Upsize to Support Growth and Achieve Positive Operating Cash Flow

Cosmos Health Submits Patent Application for Allergic Inflammation Therapy by Leveraging AI Drug Repurposing; Allergy Treatment Market Valued at $23.5 Billion

Jan 27, 2025, 3:50 PM EST - 9 months ago

Cosmos Health Submits Patent Application for Allergic Inflammation Therapy by Leveraging AI Drug Repurposing; Allergy Treatment Market Valued at $23.5 Billion

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

Jan 23, 2025, 3:35 PM EST - 9 months ago

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

VRAX

Cosmos Health Secures Two WIPO-Patented Anticancer Drugs for Prostate, Ovarian, and Colorectal Cancers, Valued at Over $24.5 Million

Jan 22, 2025, 8:00 AM EST - 9 months ago

Cosmos Health Secures Two WIPO-Patented Anticancer Drugs for Prostate, Ovarian, and Colorectal Cancers, Valued at Over $24.5 Million

Cosmos Health CEO Greg Siokas Acquires a Total of 647,809 Shares Valued at $425,000 Over the Past 32 Days

Jan 21, 2025, 3:00 PM EST - 9 months ago

Cosmos Health CEO Greg Siokas Acquires a Total of 647,809 Shares Valued at $425,000 Over the Past 32 Days

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

Jan 13, 2025, 9:20 AM EST - 10 months ago

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

VRAX

Cosmos Health Strengthens R&D Leadership and Innovation with the Appointment of Professor Dimitrios Trafalis, MD, as Head of Oncology

Dec 26, 2024, 1:30 PM EST - 10 months ago

Cosmos Health Strengthens R&D Leadership and Innovation with the Appointment of Professor Dimitrios Trafalis, MD, as Head of Oncology

Cosmos Health CEO Greg Siokas and CFO George Terzis Collectively Increase Stake by 343,000 Shares Valued at $200,000

Dec 23, 2024, 9:25 AM EST - 10 months ago

Cosmos Health CEO Greg Siokas and CFO George Terzis Collectively Increase Stake by 343,000 Shares Valued at $200,000

Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets

Nov 18, 2024, 8:00 AM EST - 1 year ago

Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets

Cosmos Health Reports Q3 2024 Results: Resilient Revenue and Gross Profit Amid 18.6% Expense Reduction; Stockholders' Equity Up 8.8% to $35M

Nov 15, 2024, 10:20 AM EST - 1 year ago

Cosmos Health Reports Q3 2024 Results: Resilient Revenue and Gross Profit Amid 18.6% Expense Reduction; Stockholders' Equity Up 8.8% to $35M

Cosmos Health Issues Letter to Shareholders

Nov 12, 2024, 12:00 PM EST - 1 year ago

Cosmos Health Issues Letter to Shareholders

Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21%

Nov 1, 2024, 12:30 PM EDT - 1 year ago

Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21%

Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands

Sep 25, 2024, 9:25 AM EDT - 1 year ago

Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands

Cosmos Health Receives Initial Orders Exceeding $500,000 for C-Scrub in the UK; Future Orders Booked at Accelerated Pace with Strong Profitability Anticipated Due to High Profit Margins

Sep 23, 2024, 12:55 PM EDT - 1 year ago

Cosmos Health Receives Initial Orders Exceeding $500,000 for C-Scrub in the UK; Future Orders Booked at Accelerated Pace with Strong Profitability Anticipated Due to High Profit Margins

Cosmos Health Expands Global Presence into India, a Market with Over 1.4Bn People, Through Exclusive Agreement to Distribute Virax Biolabs' Mpox PCR Detection Kits

Sep 23, 2024, 9:00 AM EDT - 1 year ago

Cosmos Health Expands Global Presence into India, a Market with Over 1.4Bn People, Through Exclusive Agreement to Distribute Virax Biolabs' Mpox PCR Detection Kits

Cosmos Health Enters Development Phase for CCDL24, an Innovative Multitargeting Product for Gastrointestinal Disorders, with a Market Size Valued at Over $37.5 Billion

Sep 19, 2024, 3:40 PM EDT - 1 year ago

Cosmos Health Enters Development Phase for CCDL24, an Innovative Multitargeting Product for Gastrointestinal Disorders, with a Market Size Valued at Over $37.5 Billion

Cosmos Health Releases 2024-2027 Updated Guidance; Projects Revenue of $155.8M and Adjusted EBITDA of $29.4M Annually by 2027, Driven by Strategic Focus on High-Margin Segments

Sep 18, 2024, 1:30 PM EDT - 1 year ago

Cosmos Health Releases 2024-2027 Updated Guidance; Projects Revenue of $155.8M and Adjusted EBITDA of $29.4M Annually by 2027, Driven by Strategic Focus on High-Margin Segments

Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar

Sep 16, 2024, 8:30 AM EDT - 1 year ago

Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar

VRAX

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

Sep 16, 2024, 8:30 AM EDT - 1 year ago

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

VRAX

Cosmos Health Regains Full Compliance with Nasdaq Listing Requirements

Aug 23, 2024, 9:35 AM EDT - 1 year ago

Cosmos Health Regains Full Compliance with Nasdaq Listing Requirements

Cosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits

Aug 21, 2024, 10:20 AM EDT - 1 year ago

Cosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits

VRAX

Cosmos Health Reports Q2 2024 Results: Sustains Positive Momentum with 7% Revenue Growth vs. Q1 2023 and 12.5% vs.

Aug 20, 2024, 12:20 PM EDT - 1 year ago

Cosmos Health Reports Q2 2024 Results: Sustains Positive Momentum with 7% Revenue Growth vs. Q1 2023 and 12.5% vs.

YanstersParadise
YanstersParadise Oct. 25 at 12:51 PM
$ASST $COSM $TGL $LUXX.CSE 🔥🔥🔥🔥Crypto Treasury 🔥🔥🔥🔥 🚨🚨🚨💎💎💎💎💎💎💎💎🚨🚨🚨
1 · Reply
Luvmepup
Luvmepup Oct. 25 at 12:32 PM
$COSM Baggies more worried about people posting than this crooked CEO constantly drilling them in the ass 🙄
0 · Reply
Dastock87
Dastock87 Oct. 25 at 12:20 PM
$COSM what's up with this Pup guy? He posts every 5min...
1 · Reply
Luvmepup
Luvmepup Oct. 25 at 12:07 PM
$COSM Charts showing very bullish today and tomorrow with a probable dip come Monday.
0 · Reply
Xenocyde
Xenocyde Oct. 25 at 2:21 AM
$COSM a lot of tough talk for someone who made some very very bold dumper claims this week. What was that about wouldn’t hold a dollar.
0 · Reply
Luvmepup
Luvmepup Oct. 25 at 1:56 AM
$COSM We Shorts really put an ass whooping on you baggies/bulls this week ... so much so, you people had hardly anything to try and pump about!
0 · Reply
BigPlaySnipers
BigPlaySnipers Oct. 24 at 9:45 PM
$ASST = $RR $COSM $OPEN vibes …
0 · Reply
Luvmepup
Luvmepup Oct. 24 at 8:12 PM
$COSM I don't think you baggies/bulls realize whats going on right now. That 1.02 offering is not only killing you in stock price, but it's also adding millions more to the float! Once they are done, this stock is really going to take a huge shit ... you watch!
0 · Reply
Luvmepup
Luvmepup Oct. 24 at 6:44 PM
$COSM Wheres your crooked CEO after getting his compliancee?
0 · Reply
BlackLamaPijama
BlackLamaPijama Oct. 24 at 6:43 PM
$COSM $DJT Yup. Let's get those Epstein files out.
0 · Reply
Luvmepup
Luvmepup Oct. 24 at 6:38 PM
$COSM There's that 1.02 offering price.
0 · Reply
Luvmepup
Luvmepup Oct. 24 at 6:29 PM
$COSM Food stamps will end Nov 1st because of the gov shutdown. Guarantee the Dems sign up to open the gov by Friday next week because those are mostly their voters. They couldn't give a rats ass about military and law enforcement not getting paid because those are mostly Rep voters ... you watch, this shutdown ends by Nov 1st !! $DJT
2 · Reply
gio5528
gio5528 Oct. 24 at 4:13 PM
$COSM 👀
0 · Reply
Luvmepup
Luvmepup Oct. 24 at 3:57 PM
$COSM Wouldn't it be nice if this crooked CEO dropped some bad news PR late tonight like he loves to do on Friday nights to try and hide them? lol
0 · Reply
Luvmepup
Luvmepup Oct. 24 at 3:50 PM
$COSM Hey dummies, wake up! this is what you call controlled selling!
0 · Reply
Luvmepup
Luvmepup Oct. 24 at 3:47 PM
$COSM Word on the street is that earnings announcement next month will be a complete disaster with net profits in the shitter ... once again!
0 · Reply
Luvmepup
Luvmepup Oct. 24 at 3:03 PM
$COSM This will only move when Wall Street jumps in ... and we're not jumping in 🤣😂🤣
0 · Reply
Luvmepup
Luvmepup Oct. 24 at 2:56 PM
$COSM P131 ... I thought we Shorts were supposed to be toast by now ... isn't that what you said in 2023, 2024, 2025? Let me guess ... 2026?
0 · Reply
Luvmepup
Luvmepup Oct. 24 at 2:50 PM
$COSM Tremendous sell orders happening as we speak! Has something terrible been leaked?
0 · Reply
Luvmepup
Luvmepup Oct. 24 at 1:10 PM
$COSM No volume, no buying interest ... this doesn't look familiar
0 · Reply
SlaveKing
SlaveKing Oct. 24 at 12:55 PM
$COSM This ticker runs on news. Volume is too low for TA to be reliable. One day, when it gets back to $4, will volume be a bit more consistent.
0 · Reply
Luvmepup
Luvmepup Oct. 24 at 12:39 PM
$COSM Remember all you baggies/bulls celebrating when this regained compliance? Other than helping this crooked CEO to continue using this company as a Shell, how'd that work out for this stock price?
0 · Reply